Discover what makes HBKU an innovation-based entrepreneurial
Meet the leadership making HBKU a transformative place to
Read about the people who create a unique environment for
Join an innovative organization and the people who are
Join a student body shaping tomorrow by enrolling in one of our
Our students, faculty, and scholars actively engage in innovative
world’s problems within multi-disciplinary programs.
Life at HBKU involves a transformative learning culture that
in and out of the classroom, developing innovative
citizens within Qatar and beyond.
A student-centered and educationally purposeful facility, the
Student Center is the “majlis” of Education City and serves
both formal and informal events and activities.
With housing that is accessible, sustainable, and affordable,
plenty of reasons to consider living in Education City.
Minaretein (College of Islamic Studies building), Education City
The Cancer Research Center (CRC) at QBRI focuses on understanding the
cellular and molecular basis of cancer initiation
and progression, with a focus on breast cancer, which is the most
common cancer among females globally. Breast cancer
prevalence in the Arab region is similar to that in the rest of the
world. However, some studies have suggested that
Arab women may experience more aggressive forms of breast cancer.
The CRC currently has four active research teams, each with diverse
expertise and research interests that fall within
two main themes, cancer immunology and immunotherapy, and cancer
biomarkers and therapy.
Selecting the most effective treatment during first-line therapy for
each patient (personalized medicine) improves
survival outcomes. For a subset of breast cancer patients, disease
progression may happen after primary treatment,
therefore, more effective therapies are needed.
The CRC explores several strategies to improve clinical outcome of
breast cancer patients, including harnessing the
power of the immune system, and the identification of breast cancer
risk factors and novel biomarkers for diagnosis,
prognosis, and prediction of treatment response.